These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 7682563)

  • 1. Effects of hypothyroidism and hyperthyroidism on insulin-like growth factors (IGFs) and growth hormone- and IGF-binding proteins.
    Miell JP; Taylor AM; Zini M; Maheshwari HG; Ross RJ; Valcavi R
    J Clin Endocrinol Metab; 1993 Apr; 76(4):950-5. PubMed ID: 7682563
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reversible effects of cessation and recommencement of thyroxine treatment on insulin-like growth factors (IGFs) and IGF-binding proteins in patients with total thyroidectomy.
    Miell JP; Zini M; Quin JD; Jones J; Portioli I; Valcavi R
    J Clin Endocrinol Metab; 1994 Nov; 79(5):1507-12. PubMed ID: 7525638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth hormone/insulin-like growth factor axis in patients with subclinical thyroid dysfunction.
    Akin F; Yaylali GF; Turgut S; Kaptanoglu B
    Growth Horm IGF Res; 2009 Jun; 19(3):252-5. PubMed ID: 19111490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of thyroid hormone action on the insulin-like growth factor system: all thyroid hormone effects are not growth hormone mediated.
    Näntö-Salonen K; Muller HL; Hoffman AR; Vu TH; Rosenfeld RG
    Endocrinology; 1993 Feb; 132(2):781-8. PubMed ID: 7678799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of thyroid hormone on insulin-like growth factor (IGF) and IGF-binding protein (IGFBP) expression in the neonatal rat: prolonged high expression of IGFBP-2 in methimazole-induced congenital hypothyroidism.
    Näntö-Salonen K; Glasscock GF; Rosenfeld RG
    Endocrinology; 1991 Nov; 129(5):2563-70. PubMed ID: 1718729
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The insulin-like growth factor (IGF)-binding proteins and IGF bioactivity in Laron-type dwarfism.
    Cotterill AM; Holly JM; Taylor AM; Davies SC; Coulson VJ; Preece MA; Wass JA; Savage MO
    J Clin Endocrinol Metab; 1992 Jan; 74(1):56-63. PubMed ID: 1370165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum insulin-like growth factor type 1, insulin-like growth factor-binding protein-1, and insulin-like growth factor-binding protein-3 concentrations in patients with thyroid dysfunction.
    Iglesias P; Bayón C; Méndez J; Gancedo PG; Grande C; Diez JJ
    Thyroid; 2001 Nov; 11(11):1043-8. PubMed ID: 11762714
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Levels of growth hormone, insulin-like growth factor-I (IGF-I) and -II, IGF-binding protein-1 and -3, and cortisol in prednisone-treated children with growth retardation after renal transplantation.
    Hokken-Koelega AC; Stijnen T; de Muinck Keizer-Schrama SM; Blum WF; Drop SL
    J Clin Endocrinol Metab; 1993 Oct; 77(4):932-8. PubMed ID: 7691864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in prepubertal children with exogenous obesity: effect of short- and long-term weight reduction.
    Argente J; Caballo N; Barrios V; Pozo J; Muñoz MT; Chowen JA; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2076-83. PubMed ID: 9215275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine and cardiac paracrine actions of insulin-like growth factor-I (IGF-I) during thyroid dysfunction in the rat: is IGF-I implicated in the mechanism of heart weight/body weight change during abnormal thyroid function?
    Thomas MR; Miell JP; Taylor AM; Ross RJ; Arnao JR; Jewitt DE; McGregor AM
    J Mol Endocrinol; 1993 Jun; 10(3):313-23. PubMed ID: 8373515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentrations, release, and disposal of insulin-like growth factor (IGF)-binding proteins (IGFBP), IGF-I, and growth hormone in different vascular beds in patients with cirrhosis.
    Møller S; Juul A; Becker U; Flyvbjerg A; Skakkebaek NE; Henriksen JH
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1148-57. PubMed ID: 7536200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple endocrine abnormalities of the growth hormone and insulin-like growth factor axis in patients with anorexia nervosa: effect of short- and long-term weight recuperation.
    Argente J; Caballo N; Barrios V; Muñoz MT; Pozo J; Chowen JA; Morandé G; Hernández M
    J Clin Endocrinol Metab; 1997 Jul; 82(7):2084-92. PubMed ID: 9215276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low growth hormone-binding protein in infants with congenital hypothyroidism.
    Cassio A; Cacciari E; Balsamo A; Colli C; Pasini A; Salvioli GP; Lanari M; de Iasio R; Boschi S; Pirazzoli P
    J Clin Endocrinol Metab; 1998 Oct; 83(10):3643-6. PubMed ID: 9768678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum concentrations of insulin-like growth factors (IGFs), IGF binding proteins 1 and 3 and growth hormone binding protein in obese women and the effects of growth hormone administration: a double-blind, placebo-controlled study.
    Jørgensen JO; Pedersen SB; Børglum J; Frystyk J; Ho KK; Christiansen JS; Orskov H; Blum WF; Richelsen B
    Eur J Endocrinol; 1995 Jul; 133(1):65-70. PubMed ID: 7542982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum insulin-like growth factor-I, insulin-like growth factor binding proteins, and bone mineral content in hyperthyroidism.
    Lakatos P; Foldes J; Nagy Z; Takacs I; Speer G; Horvath C; Mohan S; Baylink DJ; Stern PH
    Thyroid; 2000 May; 10(5):417-23. PubMed ID: 10884189
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IGF-1 and IGFBP in congenital and acquired hypothyroidism after long-term replacement treatment.
    Bona G; Rapa A; Boccardo G; Silvestro L; Chiorboli E
    Minerva Endocrinol; 1999 Jun; 24(2):51-5. PubMed ID: 10941423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: correlations with fetal growth.
    McIntyre HD; Serek R; Crane DI; Veveris-Lowe T; Parry A; Johnson S; Leung KC; Ho KK; Bougoussa M; Hennen G; Igout A; Chan FY; Cowley D; Cotterill A; Barnard R
    J Clin Endocrinol Metab; 2000 Mar; 85(3):1143-50. PubMed ID: 10720053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Octreotide stimulates insulin-like growth factor-binding protein-1: a potential pituitary-independent mechanism for drug action.
    Ezzat S; Ren SG; Braunstein GD; Melmed S
    J Clin Endocrinol Metab; 1992 Dec; 75(6):1459-63. PubMed ID: 1281485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
    Grinspoon S; Clemmons D; Swearingen B; Klibanski A
    J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.